Cost-effectiveness of paliperidone palmitate versus olanzapine, quetiapine and ziprazidone for the treatment of patients with schizophrenia under the brazilian private health care system perspective

May 1, 2014, 00:00
10.1016/j.jval.2014.03.1269
https://www.valueinhealthjournal.com/article/S1098-3015(14)01320-5/fulltext
Title : Cost-effectiveness of paliperidone palmitate versus olanzapine, quetiapine and ziprazidone for the treatment of patients with schizophrenia under the brazilian private health care system perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01320-5&doi=10.1016/j.jval.2014.03.1269
First page : A217
Section Title : Mental Health
Open access? : No
Section Order : 731
Categories :
Tags :
Regions :
ViH Article Tags :